Mr. Speaker, Canada has long supported the ability of WTO members to use existing flexibilities under the TRIPS agreement to respond to public health emergencies and stands ready to find solutions to any concrete challenges in WTO members' responses to COVID-19-related to or arising from the TRIPS agreement and which cannot be addressed through existing TRIPS flexibilities.
Meanwhile, Canada continues to work closely with international partners like COVAX and plays a leadership role in the ongoing effort toward ensuring the timely, equitable distribution of vaccines, therapeutics and diagnostics to middle and low-income countries.